Latest filing published 01 Apr 2026 for NEUROONE MEDICAL TECHNOLOGIES Corp, €608.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Steve Mertens on record concern NEUROONE MEDICAL TECHNOLOGIES Corp, in the capacity of senior executive. In total, 36 filings cover trades dated from 3 February 2022 to 31 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 1 April 2026, the filings show a share grant worth €608 in NEUROONE MEDICAL TECHNOLOGIES Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations